MKNK2 (Q9HBH9) - Overview - Molecular Target Synopsis
MKNK2, MAP kinase-interacting serine/threonine-protein kinase 2
Enzyme Classification 184.108.40.206
Also Known as MKNK2_HUMAN, MKNK2, GPRK7, MNK2
Serine/threonine-protein kinase that phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap. Required for mediating PP2A-inhibition-induced EIF4E phosphorylation. Triggers EIF4E shuttling from cytoplasm to nucleus. Isoform 1 displays a high basal kinase activity, but isoform 2 exhibits a very low kinase activity. Acts as a mediator of the suppressive effects of IFNgamma on hematopoiesis. Negative regulator for signals that control generation of arsenic trioxide As(2)O(3)-dependent apoptosis and anti-leukemic responses. Involved in anti-apoptotic signaling in response to serum withdrawal. Monomer. Interacts with the C-terminal regions of EIF4G1 and EIF4G2; this interaction is promoted when MAPK pathways are repressed but repressed upon ERK proteins activation. Also binds to dephosphorylated MAPK3/ERK1 and MAPK1/ERK2. Isoform 1 interaction with phosphorylated MAPK3/ERK1 and MAPK1/ERK2 protects it from dephosphorylation and inactivation. Isoform 2 interacts with ESR2 and EIF4E in the nucleus.
|Protein Length||Ensembl Gene||Ensembl Transcript||Ensembl Protein||Uniprot Isoform|
|465||ENSG00000099875||ENST00000250896, ENST00000591601||ENSP00000250896, ENSP00000467811||Q9HBH9-1|
UniProt: MKNK2 is active in the following subcellular-locations: cytoplasm, nucleus, pml body.
GO terms: MKNK2 is active in the following subcellular-locations: cytoplasm, nuclear body, nucleoplasm, nucleus, PML body.